Forecast: Pharmaceuticals in Dosage Market Size Value in Thailand

From 2013 to 2023, the pharmaceutical dosage market in Thailand displayed fluctuating growth, peaking at $4.2307 billion in 2021 before slipping slightly to $3.9376 billion in 2023. This period was marked by notable volatility with annual growth rates ranging from a high of 9.4% in 2015 to a decline as steep as -8% in 2022. The five-year CAGR up to 2023 was a modest 0.91%, suggesting a general market deceleration.

Looking ahead, the market is anticipated to stabilize, growing from $4.0118 billion in 2024 to $4.1701 billion by 2028, representing a forecasted five-year CAGR of 0.78%. Although the expected annual growth of 3.95% overall is moderate, it hints at a steadier industry compared to the previous decade.

Future trends to watch for include:

• Increasing demand for innovative and high-value pharmaceuticals driven by an aging population.
• Expanding healthcare infrastructure and government policy changes influencing the market dynamics.
• Potential market disruptions from global health challenges and regulatory shifts.